Alector, Inc. Accumulated Other Comprehensive Income
Alector, Inc. (ALEC) had Accumulated Other Comprehensive Income of -$126.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$126.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$104.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $166.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $197.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$126.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$104.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $166.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $197.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $96.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $191.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $261.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $931.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$620.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$403.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $184.00K 10-K · filed 2025-02-26 |
| 2023-09-30 | -$721.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$1.39M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$2.20M 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$4.58M 10-K · filed 2024-02-27 |
| 2022-09-30 | -$6.74M 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$6.22M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$3.94M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$943.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | -$41.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $203.00K 10-Q · filed 2021-08-03 |
| 2021-03-31 | $410.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $614.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $1.09M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $1.85M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $2.78M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $142.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $226.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $441.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $108.00K 10-Q · filed 2019-05-13 |
| 2018-12-31 | -$42.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |